Roxana Coras1, Arthur Kavanaugh2, Tristan Boyd2, Doquyen Huynh2, Kim A Lagerborg2, Yong-Jiang Xu2, Sarah B Rosenthal3, Mohit Jain2, Monica Guma4. 1. Department of Medicine, School of Medicine, University of California, San Diego, USA; and Department of Medicine, Autonomous University of Barcelona, Spain. 2. Department of Medicine, School of Medicine, University of California, San Diego, USA. 3. Center for Computational Biology and Bioinformatics, University of California, San Diego, USA. 4. Department of Medicine, School of Medicine, University of California, San Diego, USA; and Department of Medicine, Autonomous University of Barcelona, Spain. mguma@ucsd.edu.
Abstract
OBJECTIVES: Dietary intake of choline has been linked to systemic inflammation through the microbial production of two metabolites, trimethylamine (TMA) and trimethylamine-N-oxide (TMAO). Herein we explore the association between choline metabolites and inflammation in psoriatic arthritis (PsA) patients. METHODS: Thirty-eight patients with PsA, all of whom satisfied the CASPAR classification criteria for PsA, were studied. Outcomes reflecting the activity of peripheral arthritis as well as skin psoriasis, Disease Activity Score (DAS)28, Clinical Disease Index (CDAI) and Body Surface Area (BSA) were assessed. Serum concentration of choline metabolites (choline, TMA, TMAO, betaine and carnitine) were determined by LC-MS, and metabolite levels associated with disease scores. RESULTS: Among the 38 PsA patients included, the mean DAS28PCR was 2.74±1.29. Twenty-seven patients had active skin disease, with an average BSA of 7.2±16.22. TMAO, but not TMA or choline, significantly correlated with measures of disease activity for both skin and peripheral joints. CONCLUSIONS: In our cohort, only TMAO, but not TMA, choline, betaine or carnitine, was associated with inflammation in PsA patients, establishing a mechanistic link between TMAO and PsA phenotypes. Future studies will explore the modulation of TMAO and disease severity in PsA.
OBJECTIVES: Dietary intake of choline has been linked to systemic inflammation through the microbial production of two metabolites, trimethylamine (TMA) and trimethylamine-N-oxide (TMAO). Herein we explore the association between choline metabolites and inflammation in psoriatic arthritis (PsA) patients. METHODS: Thirty-eight patients with PsA, all of whom satisfied the CASPAR classification criteria for PsA, were studied. Outcomes reflecting the activity of peripheral arthritis as well as skin psoriasis, Disease Activity Score (DAS)28, Clinical Disease Index (CDAI) and Body Surface Area (BSA) were assessed. Serum concentration of choline metabolites (choline, TMA, TMAO, betaine and carnitine) were determined by LC-MS, and metabolite levels associated with disease scores. RESULTS: Among the 38 PsA patients included, the mean DAS28PCR was 2.74±1.29. Twenty-seven patients had active skin disease, with an average BSA of 7.2±16.22. TMAO, but not TMA or choline, significantly correlated with measures of disease activity for both skin and peripheral joints. CONCLUSIONS: In our cohort, only TMAO, but not TMA, choline, betaine or carnitine, was associated with inflammation in PsA patients, establishing a mechanistic link between TMAO and PsA phenotypes. Future studies will explore the modulation of TMAO and disease severity in PsA.
Authors: W H Wilson Tang; Zeneng Wang; Bruce S Levison; Robert A Koeth; Earl B Britt; Xiaoming Fu; Yuping Wu; Stanley L Hazen Journal: N Engl J Med Date: 2013-04-25 Impact factor: 91.245
Authors: Knut M Wittkowski; Craig Leonardi; Alice Gottlieb; Alan Menter; Gerald G Krueger; Paul W Tebbey; Jennifer Belasco; Razieh Soltani-Arabshahi; John Gray; Liz Horn; James G Krueger Journal: PLoS One Date: 2011-06-01 Impact factor: 3.240
Authors: Zeneng Wang; Elizabeth Klipfell; Brian J Bennett; Robert Koeth; Bruce S Levison; Brandon Dugar; Ariel E Feldstein; Earl B Britt; Xiaoming Fu; Yoon-Mi Chung; Yuping Wu; Phil Schauer; Jonathan D Smith; Hooman Allayee; W H Wilson Tang; Joseph A DiDonato; Aldons J Lusis; Stanley L Hazen Journal: Nature Date: 2011-04-07 Impact factor: 49.962
Authors: Ji Miao; Alisha V Ling; Praveen V Manthena; Mary E Gearing; Mark J Graham; Rosanne M Crooke; Kevin J Croce; Ryan M Esquejo; Clary B Clish; David Vicent; Sudha B Biddinger Journal: Nat Commun Date: 2015-04-07 Impact factor: 14.919
Authors: Katharine Lu Yang; Alannah Lejeune; Gregory Chang; Jose U Scher; Sergei B Koralov Journal: Semin Immunopathol Date: 2021-02-10 Impact factor: 11.759
Authors: Magnhild E Macpherson; Johannes R Hov; Thor Ueland; Tuva B Dahl; Martin Kummen; Kari Otterdal; Kristian Holm; Rolf K Berge; Tom E Mollnes; Marius Trøseid; Bente Halvorsen; Pål Aukrust; Børre Fevang; Silje F Jørgensen Journal: Front Immunol Date: 2020-09-16 Impact factor: 7.561